Diagnostyka

Diagnostyka Net Margin

The Net Profit Margin of Diagnostyka (DIA.WA) as of Oct 27, 2026 is 10.44 %. In the previous year, Net Profit Margin was 11.45 % — a change of -8.85% (lower).

Net Margin

10.44 %

YoY

-8.85%

Last updated:

Net Profit Margin of Diagnostyka is 2025 10.44 % . Net Profit Margin of Diagnostyka was 2024 11.45 % . It decreases by -8.85% lower compared to the previous year.

For Diagnostyka, the net margin of 10.7% is down versus 30.7% a few years ago.

The Diagnostyka Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2021
30.27 PLN
Jan 1, 2022
11.66 PLN
Jan 1, 2023
7.77 PLN
Jan 1, 2024
11.45 PLN
Jan 1, 2025
10.44 PLN
The Diagnostyka Net Margin history
YEARNet MarginYoY
10.44 %-8.85%
11.45 %+47.33%
7.77 %-33.35%
11.66 %-61.47%
30.27 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Diagnostyka Stock analysis

What does Diagnostyka do? Diagnostyka SA generates revenue through its network of 180 laboratories and 1,100 Sampling Labs across Poland, offering over 3,000 test types including hematology, infection diagnostics, allergology, and hormonal diagnostics. The company provides both routine and specialist laboratory services, with tests available with or without a physician's referral, catering to individual patients and healthcare providers. Its specialization in molecular biology, autoimmune diagnostics, and blood collection drives demand from private individuals seeking direct access to medical analysis without a doctor's prescription. The firm's revenue model relies on a comprehensive service chain from biological material collection and transportation to final analysis results, serving a broad customer base including patients, clinics, and hospitals. With a focus on accessible diagnostics, Diagnostyka SA expands its market reach through its extensive lab network, enabling widespread availability of medical testing services throughout Poland. The company's ability to deliver specialized tests like molecular biology and autoimmune diagnostics differentiates its offerings in the healthcare sector. Diagnostyka is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Diagnostyka stock

Net Profit Margin of Diagnostyka is 10.44 % in 2025.

Net Profit Margin of Diagnostyka changed from 11.45 % to 10.44 %, representing a -8.85% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Diagnostyka since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Diagnostyka with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Diagnostyka

All Key Metrics — Diagnostyka